Logo image of ALIMP.PA

IMPLANET (ALIMP.PA) Stock Fundamental Analysis

Europe - EPA:ALIMP - FR0013470168 - Common Stock

0.317 EUR
+0.04 (+16.12%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

1

ALIMP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. ALIMP may be in some trouble as it scores bad on both profitability and health. ALIMP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALIMP has reported negative net income.
ALIMP had a negative operating cash flow in the past year.
ALIMP had negative earnings in each of the past 5 years.
ALIMP had a negative operating cash flow in each of the past 5 years.
ALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

ALIMP has a worse Return On Assets (-29.32%) than 79.31% of its industry peers.
The Return On Equity of ALIMP (-600.55%) is worse than 87.93% of its industry peers.
Industry RankSector Rank
ROA -29.32%
ROE -600.55%
ROIC N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMP.PA Yearly ROA, ROE, ROICALIMP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

ALIMP has a Gross Margin (53.05%) which is in line with its industry peers.
ALIMP's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALIMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
ALIMP.PA Yearly Profit, Operating, Gross MarginsALIMP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ALIMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALIMP has been increased compared to 1 year ago.
ALIMP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALIMP has an improved debt to assets ratio.
ALIMP.PA Yearly Shares OutstandingALIMP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALIMP.PA Yearly Total Debt VS Total AssetsALIMP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that ALIMP is in the distress zone and has some risk of bankruptcy.
ALIMP has a worse Altman-Z score (0.30) than 67.24% of its industry peers.
A Debt/Equity ratio of 3.69 is on the high side and indicates that ALIMP has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.69, ALIMP is doing worse than 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.69
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC7.17%
ALIMP.PA Yearly LT Debt VS Equity VS FCFALIMP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

ALIMP has a Current Ratio of 0.85. This is a bad value and indicates that ALIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALIMP (0.85) is worse than 87.93% of its industry peers.
ALIMP has a Quick Ratio of 0.85. This is a bad value and indicates that ALIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALIMP (0.38) is worse than 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.38
ALIMP.PA Yearly Current Assets VS Current LiabilitesALIMP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.71% over the past year.
Looking at the last year, ALIMP shows a very strong growth in Revenue. The Revenue has grown by 26.31%.
ALIMP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.89% yearly.
EPS 1Y (TTM)73.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.87%
Revenue 1Y (TTM)26.31%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%66.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMP.PA Yearly Revenue VS EstimatesALIMP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALIMP.PA Yearly EPS VS EstimatesALIMP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALIMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMP.PA Price Earnings VS Forward Price EarningsALIMP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMP.PA Per share dataALIMP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALIMP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMPLANET

EPA:ALIMP (9/25/2025, 7:00:00 PM)

0.317

+0.04 (+16.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap39.82M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.23
P/FCF N/A
P/OCF N/A
P/B 54.77
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.07
BVpS0.01
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.32%
ROE -600.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.05%
FCFM N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 3.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.33%
Cap/Sales 5.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.38
Altman-Z 0.3
F-Score4
WACC7.17%
ROIC/WACCN/A
Cap/Depr(3y)21.16%
Cap/Depr(5y)17.19%
Cap/Sales(3y)3.98%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.31%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%66.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.49%
OCF growth 3YN/A
OCF growth 5YN/A